Takeda Announces New Assignment of a Director and Corporate Officers, Including Change of the Organization Name

Osaka, Japan, October 1, 2011 --- Takeda Pharmaceutical Company Limited (“Takeda”) today announced the new assignment of a director and corporate officers, including change of the organization name from International Operations (Asia) to International Operations (North Asia), which was decided at Board of Directors’ Meeting, and the details are as follows;

1. New Assignment to a Director effective October 1, 2011;
New assignment	Previous assignment	Name
Director, Executive Vice President, International Operations (Americas/Europe), Chief Executive Officer, Nycomed A/S	(Director, Executive Vice President, International Operations (Americas/Europe) )	Frank Morich, M.D., Ph.D.

2. New Assignment to Corporate Officers effective October 1, 2011;
New assignment	Previous assignment	Name
Corporate Officer, Senior Vice President, International Operations (North Asia)	(Corporate Officer, Senior Vice President, International Operations (Asia) )	Haruhiko Hirate
Corporate Officer, Chief Integration Officer, Nycomed A/S	Corporate Officer, Chief Integration Officer, Takeda Pharmaceuticals International, Inc.	Shinji Honda
Corporate Officer, Chief Executive Officer, Takeda Pharmaceuticals Europe Limited, Head of Europe and Canada Commercial Operations, Nycomed A/S	Corporate Officer, Chief Executive Officer, Takeda Pharmaceuticals Europe Limited	Trevor Smith

###

Latest News Release